Clinical Trials Logo
  1. Home
  2. Insomnia Chronic
  3. NCT04252638

Acceptance and Commitment Therapy as a New Treatment for Adults With Insomnia Disorder

Insomnia Chronic Clinical Trial

Official title:
Acceptance and Commitment Therapy as a New Treatment for Adults With Insomnia Disorder

Clinical Trial Summary

Acceptance and Commitment Therapy plus sleep restriction (ACT) will be compared to Cognitive Behavioral Therapy for insomnia (CBT-I). CBT-I is the first line treatment for insomnia according to current guidelines. The aim of the study is to investigate the efficacy of ACT, compared to CBT-I, for the improvement of sleep-related quality of life and insomnia severity.

Clinical Trial Description

Insomnia is a major health problem worldwide and a risk factor for the onset of other diseases, including cardiovascular and mental disorders. The prevalence of insomnia is 10% in the adult population. Cognitive Behavioral Therapy for insomnia (CBT-I) is the most effective treatment according to current guidelines. However, with response rates of around 70% and remission rates of around 40%, many patients need additional treatment. Common difficulties are that i) behavioral treatment elements, especially sleep restriction, are not implemented by patients, and that ii) quality of life does not improve despite improvements in sleep. Long-term pharmacological treatment is not recommended because it is often associated with a loss of efficacy and the risk of severe side effects. The aim of this research project is to improve behavioral treatment options for patients with insomnia. Acceptance and Commitment Therapy (ACT) is a new form of behavioral therapy. Efficacy, primarily an improvement of quality of life, has already been proven for other conditions including chronic pain and depression - however, no controlled study in patients with insomnia has yet been conducted. In a feasibility study, our workgroup provided first evidence that this treatment is feasible and potentially efficacious mainly for the improvement of sleep related quality of life. The current proposal is designed to extend this preliminary work in form of a prospective randomized controlled pilot trial. ACT will be compared with the gold standard treatment (CBT-I) in 60 patients with a primary diagnosis of insomnia disorder. The primary aim of this research is to test for differential efficacy, i.e. whether ACT is more effective for the improvement of i) insomnia severity and ii) sleep-related quality of life. The planned study is prospective, randomized, controlled, confirmatory, two-armed, single-blinded. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04252638
Study type Interventional
Source University of Bern
Contact
Status Completed
Phase N/A
Start date January 13, 2020
Completion date May 1, 2022
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05561829 - Determination of Optimal Sleep Treatment Elements - MOST N/A
Completed NCT05561790 - Determination of Optimal Sleep Treatment Elements - Pilot N/A
Recruiting NCT06053840 - An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients With Severe Insomnia Phase 4
Terminated NCT04059302 - Internet Cognitive Behavioral Therapy for Insomnia to Prevent Cardiovascular Disease N/A
Recruiting NCT04545606 - Targeting Insomnia in School Aged Children With Autism Spectrum Disorder N/A
Completed NCT04073992 - Chronic Insomnia and CSF Markers of Dementia - Effects of Treatment N/A
Completed NCT03623438 - Self-administered Acupressure for Insomnia Disorder N/A
Completed NCT04565223 - Feasibility and Acceptability of Cognitive Behavioral Therapy for Chronic Insomnia in a Primary Care N/A
Not yet recruiting NCT06351839 - Sleep Well Despite Persistent Pain Symptoms N/A
Completed NCT05078112 - Sleep Device Testing N/A
Active, not recruiting NCT05917379 - The Safety and Efficacy of FMT in Patients With CID Phase 1/Phase 2
Active, not recruiting NCT04627480 - Evaluation of a Neurostimulation Device for Insomnia: A Randomized Trial Phase 4
Completed NCT03441191 - Audio-visual Stimulation for Sleep Promotion in Older Adults With Osteoarthritis Pain N/A
Completed NCT04406103 - Protocol - Your Answers When Needing Sleep in New Brunswick N/A
Recruiting NCT05373537 - Treatment to Improve Sleep in Caregivers With Insomnia and a Child With Autism N/A
Recruiting NCT05797324 - Light Therapy in Modulating the Clinical Phenotype of Patients With Primary and Comorbid Chronic Insomnia. N/A
Completed NCT02967185 - Intraindividual Variability in Sleep and Cognitive Performance in Older Adults Phase 2
Recruiting NCT06410495 - Digital Dyadic Family Based Intervention to Improve Sleep in Children With ODD and Their Parents: NiteCAPP SINCC (Pilot) N/A
Completed NCT03015766 - Auricular Acupressure for Hemodialysis Patients With Insomnia N/A
Completed NCT03482856 - Cognitive Behavioural Therapy for Insomnia in Chronic Spinal Pain N/A